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Abstract: Diets high in fruits and vegetables are generally believed protective against several chronic diseases. One suggested 
mechanism is a reduction in oxidative stress. The carotenoids, nutrients found in colored fruits and vegetables, possess 
antioxidant properties in vitro, but their role in humans is less well documented. The aim of this cross-sectional study was 
to explore the relationships between the most abundant plasma carotenoids (alpha-carotene, beta-carotene, lycopene, lutein, 
zeaxanthin and beta-cryptoxanthin), as well as grouped carotenoids (total xanthophylls, carotenes and carotenoids), and 
urinary excretion of the F2-isoprostanes (F2-IsoPs), stable and speciﬁ  c biomarkers of oxidative damage to lipids. Two F2-IsoP 
measures were utilized: total F2-IsoPs and 8-iso-PGF2α. The study population (N = 52) was drawn from a study among 
patients curatively treated for early-stage head and neck cancer. Unadjusted linear regression analyses revealed signiﬁ  cant 
inverse associations between plasma lutein, total xanthophylls and both F2-IsoP measures at baseline. After control for 
potential confounders, all individual and grouped xanthophylls remained inversely associated with the F2-IsoP measures, 
but none of these associations achieved signiﬁ  cance. The carotenes were not inversely associated with total F2-IsoPs or 
8-iso-PGF2a concentrations. The ﬁ  nding of consistent inverse associations between individual and grouped xanthophylls, 
but not individual and grouped carotenes, and F2-IsoPs is intriguing and warrants further investigation.
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Introduction
A number of studies support the hypothesis that diets high in fruits and vegetables protect against a 
variety of chronic diseases, including certain cancers and cardiovascular disease.
1–5 It has long been 
suggested that carotenoids, which are found in fruits and vegetables, might be responsible for these 
protective effects as carotenoids have antioxidant properties in vitro and may act similarly in humans. 
Thus carotenoids may reduce oxidative stress, a state that has been associated with a number of diseases 
and which can be deﬁ  ned as “an imbalance between increased exposure to free radicals, principally 
derived from oxygen, and antioxidant defenses.”
6
Carotenoids are fat-soluble pigments.
7 Of the carotenoids that are quantiﬁ  able in human plasma, the 
most plentiful are alpha-carotene, beta-carotene, lycopene, lutein, zeaxanthin and beta-cryptoxanthin.
8 
In vitro studies have demonstrated that the carotenoids (particularly beta-carotene) are efﬁ  cient scav-
engers of peroxyl radicals,
9–11 which play a critical role in lipid peroxidation.
12 The fact that carotenoids 
are lipid-soluble increases the plausibility that these nutrients may exert a protective effect against 
oxidative damage to lipids in vivo.
11 Carotenoids can be classiﬁ  ed into oxygenated carotenoids (e.g. lutein, 
zeaxanthin and beta-cryptoxanthin), known as xanthophylls, and hydrocarbon carotenoids (e.g. alpha-
carotene, beta-carotene and lycopene), known as carotenes.
7 Due to differences in chemical structure 
and polarity, carotenoids in these two classes attach at distinct locations of the cell membrane and thus 
may differentially inﬂ  uence the susceptibility of lipids to oxidation.
11
Oxidative stress can be measured using various biomarkers of oxidative damage to DNA, proteins 
and lipids.
13 In the early 1990s, a major advance in measuring oxidative damage of lipids was made 
with the discovery of the F2-Isoprostanes (F2-IsoPs) in vivo.
14 The F2-IsoPs are stable and speciﬁ  c 
products of free radical catalyzed, nonenzymatic lipid peroxidation of arachidonic acid and detectable 
in all biological ﬂ  uids.
14,15 As F2-IsoP concentrations increase substantially in animal and human models 18
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of oxidative stress,
14,16,17 these compounds appear 
to be reliable markers of free radical induced 
oxidative damage. One of the most abundant and 
commonly measured F2-IsoPs is 8-iso-PGF-2α, also 
known as 8-epi-PGF2α or 15-F2t-IsoP.
6
The evidence from studies examining the rela-
tionship between F2-IsoPs and fruit and vegetable 
intake or carotenoids is mixed. Several studies have 
documented a decrease in urinary F2-IsoPs with 
increased dietary intake of fruits and vegetables,
18–21 
while other studies have not observed this 
effect.
22–24
The limited research that has been performed 
on the relationships between carotenoids, both the 
xanthophylls and carotenes, and F2-IsoPs in 
humans is not consistent. Cross-sectional studies 
have found signiﬁ  cant inverse associations between 
plasma F2-IsoPs and plasma beta-carotene,
25 as 
well as between urinary 8-iso-PGF2α and plasma 
xanthophyll concentrations.
26 A longitudinal study 
among children at high risk for developing type 
I diabetes demonstrated a signiﬁ  cant inverse rela-
tionship between plasma alpha-carotene:total lipid 
ratio and urinary F2-IsoPs.
27 Additionally, several 
trials involving consumption of foods rich in lyco-
pene or a mixture of carotenoids and other nutrients 
found signiﬁ  cant reductions in F2-IsoP concentra-
tions after the intervention period.
28–30 Decreased 
F2-IsoP concentrations were also observed after 
consumption of supplements containing beta-
carotene alone or in combination with vitamin C 
and vitamin E.
31,32 The trial with beta-carotene 
alone did not ﬁ  nd a signiﬁ  cant reduction, although 
this could be due to small sample size.
32
However, other studies have not observed a 
protective effect of carotenoids against oxidative 
damage to lipids. Most of these null ﬁ  ndings were 
obtained using measures other than F2-IsoPs as 
biomarkers of lipid peroxidation,
33–42 and in one 
crossover trial, consumption of a tomato-based 
drink containing relatively small amounts of lyco-
pene (5.7 mg) and beta-carotene (1 mg) among 
other nutrients for 26 days was not associated 
with a signiﬁ  cant change in urinary 8-iso-PGF2α 
excretion.
43
Given the promising ﬁ  ndings of in vitro studies 
and the limited epidemiologic studies using 
F2-IsoPs as outcomes, we conducted this analysis 
to explore the relationships between carotenoid 
and F2-IsoP concentrations in humans. We exam-
ined concentrations of the six major carotenoids 
found in human plasma, as well as grouped 
xanthophyll and carotene carotenoids and total 
carotenoids, in relation to concentrations of urinary 
F2-IsoPs using blood and urine samples collected 
on the same day. We hypothesized that inverse 
associations would be observed between the carot-
enoids and F2-IsoP measures. In addition, we 
hypothesized that a different relationship might be 
seen between the xanthophyll carotenoids and 
urinary F2-IsoPs compared to the carotenes and 
urinary F2-IsoPs.
Materials and Methods
Study population
The subjects in this analysis were drawn from 75 
curatively treated patients who were identiﬁ  ed as 
having been diagnosed with early-stage (in situ, 
Stage I or Stage II) cancer of the larynx, pharynx 
or oral cavity between January 1, 1997 and 
February 28, 2001 in Connecticut by the Rapid 
Case Ascertainment Shared Resource of the Yale 
Cancer Center (RCA). RCA acts as an agent of the 
Connecticut Tumor Registry (CTR).
The CTR is a population-based registry that has 
been part of the National Cancer Institute’s Surveil-
lance, Epidemiology and End Results (SEER) 
Program since its inception in 1973. All procedures 
were approved by the Yale University School of 
Medicine Human Investigation Committee, the 
Connecticut Department of Public Health Human 
Investigation Committee and the participating 
hospitals. In the process of case ascertainment 
through RCA, certain data used in this study were 
obtained from the Connecticut Tumor Registry 
located in the Connecticut Department of Public 
Health. The authors assume full responsibility for 
analyses and interpretation of these data.
All patients gave informed consent to participate 
in a randomized dietary behavioral intervention 
study. The study has been described in detail else-
where.
44 Brieﬂ  y, the study goal was to increase fruit 
and vegetable consumption in patients with early-
stage, curatively treated head and neck cancer. A cri-
terion for eligibility was that patients could not be 
taking more than 5 mg of supplemental beta-carotene 
per day at the time of recruitment. To be included in 
the present analysis, participants required baseline 
values for the two study outcomes, total F2-IsoPs 
and 8-iso-PGF2α, quantiﬁ  ed from spot urine samples, 
and had to have assessment of baseline plasma 
carotenoids, quantiﬁ  ed from blood samples.19
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Baseline assessment
After obtaining written informed consent, baseline 
in-person assessments were made. The purpose of 
the baseline assessment was three-fold: to collect 
a spot urine sample to determine isoprostane excre-
tion; to perform a blood-draw to ascertain plasma 
carotenoid concentrations; and to collect informa-
tion on dietary, demographic and other factors of 
interest. Demographic variables assessed included 
age, sex, race, education, income and marital sta-
tus. Further items on the questionnaire inquired 
about weight and height (to allow calculation of 
body mass index, BMI), alcohol consumption, 
smoking habits and use of beta-carotene dietary 
supplements. Dietary intake was assessed using 
the Fred Hutchinson Cancer Research Center Food 
Frequency Questionnaire, version 1992; the refer-
ence period was the prior month. Subjects were 
asked to abstain from fruit, vegetables, fruit juices 
and vitamin supplements for 6 hours prior to the 
visit so that carotenoid and F2-IsoP values would 
more accurately represent basal levels of these 
compounds in vivo.
45
Collection of urines and analysis 
for total F2-IsoPs and 8-iso-PGF2α
All participants were asked to provide a spot urine 
sample at the baseline visit to allow determination 
of total F2-IsoP and 8-iso-PGF2α concentrations. 
Following collection, the samples were kept cool 
during transportation to the laboratory, aliquoted 
and frozen at −70 °C until shipped on dry ice to 
the Jean Mayer USDA Human Nutrition Research 
Center on Aging (HNRCA) at Tufts University in 
Boston, Massachusetts for analysis. Total F2-IsoP 
and 8-iso-PGF-2α concentrations were determined 
using high-performance liquid chromatography 
with gas chromatography/mass spectroscopy as 
described elsewhere.
46 Final F2-IsoP concentra-
tions were expressed as nanograms isoprostane per 
milliliter urine (ng/ml), based on prior work in our 
laboratory showing a signiﬁ  cant positive associa-
tion between smoking and 8-iso-PGF-2α expressed 
per ml urine, but not between smoking and 8-iso-
PGF-2α standardized to creatinine.
32
Collection of blood samples 
and analysis for carotenoid 
concentrations
Interviewer-phlebotomists collected baseline blood 
samples from each subject in heparinized (green top) 
vacutainer tubes. After separation of the plasma 
portion of the blood, samples were stored at −70 °C 
until shipping and analysis at the HNRCA. Prior 
to the separation process, which occurred no more 
than 4 hours after the blood draw, samples were 
kept in a cold, dark location. Plasma samples were 
prepared for extraction using 200 μl of each 
sample and 0.5 ml 0.9% saline. Echinenone, in 
ethanol, was used as an internal standard. Two 
extraction steps were performed, ﬁ  rst using 2 ml 
CHCl3:CH3OH (2:1, v:v) and then 3 ml hexane. 
Following each extraction step, the mixture was 
vortexed then centrifuged at 800 × g for 15 min at 
4 °C. Additionally, the products obtained from the 
two extractions, the CHCl3 and hexane layers, 
respectively, were evaporated to dryness under 
nitrogen and combined. The mixture was then 
redissolved in 150 μl ethanol, vortexed and soni-
cated for 30 seconds. From each sample, a 50 μl 
aliquot was used for HPLC analysis. Before the 
procedure was begun, each HPLC solvent was 
passed through a 0.45 μm membrane ﬁ  lter and 
degassed and all carotenoid standards were stored 
at −70 °C.
The HPLC system consists of a 616 LC pump 
(Waters Corp., Milford, MA), Waters 717 plus 
autosampler (Waters Corp., Milford, MA), a C30 
carotenoid column (3 μm, 150 × 4.6 mm, YMC, 
Wilmington, NC) and Waters 994 programmable 
photodiode array detector. The gradient reversed-
phase HPLC procedure for plasma carotenoids has 
been described.
47 The plasma data for this study 
were collected and analyzed using Millenium 
32 Software (version 3.05.01, Windows NT, Waters 
Corp. 1998). Quantiﬁ  cation of the carotenoids was 
accomplished by determining peak areas in the 
HPLC chromatograms calibrated against known 
amounts of standards. Concentrations were cor-
rected for extraction and handling losses by 
monitoring the recovery of the internal standards. 
The lower limit of detection was 0.2 pmol for each 
carotenoid and only one subject fell below this 
level (for the alpha-carotene measure). For the 
purposes of this analysis, all three beta-carotene 
isomers were summed and all four lycopene iso-
mers were summed to yield total beta-carotene and 
total lycopene measures.
Data analysis
All analyses were performed using SAS, version 9.1 
(SAS Institute, Cary, NC). Age, BMI, plasma 20
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concentrations of alpha-tocopherol (μg/dl) and 
dietary intakes of alcohol (g/day), vitamin C 
(mg/day) and fruits and vegetables (servings per 
day) were maintained as continuous variables. Sex, 
race (two levels), education (four levels), income 
(four levels), alcohol consumption (three levels), 
smoking status (two levels), marital status (two 
levels) and beta-carotene supplementation (three 
levels) were treated as categorical. For marital 
status, those who were never married, separated, 
widowed or divorced were combined into one 
category and those who were married or living as 
married comprised a second category. BMI was 
calculated by dividing each subject’s weight (in kg) 
by his or her height (in m
2). To categorize alcohol 
consumption, each subject was classiﬁ  ed into one 
of three categories: never/occasional drinker, for-
mer regular drinker and current regular drinker. 
The fruit and vegetable intake variable was con-
structed by summing servings of fruits and servings 
of vegetables consumed per day.
Median concentrations of the two study out-
comes, total F2-IsoP and 8-iso-PGF2α, expressed 
as ng isoprostane per ml urine, were compared 
across levels of binary independent variables via 
Wilcoxon Rank Sum tests. Continuous predictors 
were divided at the median for the purposes of this 
analysis. Additionally, single-factor ANOVA was 
used to compare mean transformed concentrations 
of each outcome across levels of categorical inde-
pendent variables with more than two levels. Log 
and square-root transformations were used to nor-
malize the distributions of 8-iso-PGF2α and total 
F2-IsoPs, respectively. Independent variables con-
sidered in Wilcoxon or ANOVA tests included 
demographic factors (age, sex, education, income 
and marital status), as well as alcohol consump-
tion and smoking status, BMI, plasma alpha-
tocopherol, dietary vitamin C, dietary fruit and 
vegetable intake, beta-carotene supplement use, the 
six plasma carotenoids of interest (alpha-carotene, 
beta-carotene, lycopene, lutein, zeaxanthin, and beta-
cryptoxanthin), total xanthophyll concentration 
(sum of lutein, zeaxanthin and beta-cryptoxanthin 
plasma concentrations), total carotene concentra-
tion (sum of alpha-carotene, beta-carotene and 
lycopene plasma concentrations) and total plasma 
carotenoid concentration (sum of xanthophyll and 
carotene concentrations). Statistical signiﬁ  cance 
was deﬁ  ned at the 0.05 level.
The relationships between concentrations of 
plasma carotenoids and total F2-IsoPs and 
8-iso-PGF2α were also explored via simple and 
multiple linear regression. All carotenoid measures 
were log-transformed prior to these analyses to 
normalize the distributions. The transformed 
F2-IsoP measures noted above were also used. 
Carotenoids considered were the six individual 
carotenoids, as well as total xanthophylls, total 
carotenes and total carotenoids.
Due to the strong correlation between individual 
carotenoids (e.g. alpha-carotene and beta-carotene 
rho   0.7), separate regression models were gen-
erated for each carotenoid variable with each of 
the two F2-IsoP outcomes. Each multiple linear 
regression model included the following 
independent variables: smoking status, alcohol 
consumption, age, dietary vitamin C, plasma alpha-
tocopherol, sex, BMI and education. These factors 
were selected as, based on a review of the literature, 
each was thought to be a potential confounder of 
the associations between concentrations of the 
carotenoids and the F2-IsoPs.
Results
Of the 75 Fruit and Vegetable Trial participants, 
52 had baseline measurements for total F2-IsoPs, 
8-iso-PGF2α and plasma carotenoids of interest 
and thus were eligible for inclusion in these 
analyses. Eight of the 75 participants in the inter-
vention trial did not have baseline blood or urine 
samples, another six had blood samples, but not 
urine samples and another nine had urine samples, 
but not blood samples. Selected demographic and 
other characteristics of the study population are 
presented in Table 1. Of the 52 participants, 73% 
were male and almost all (50/52) were white, 
non-Hispanic. Seven of the participants were 
current smokers (mean pack-years = 83.3; sd ± 29.5) 
and 40 were former smokers (mean pack-years 
= 43.9; sd ± 26.7). The participants’ mean BMI 
was 26.2 kg/m
2, indicating that participants on 
average tended to be overweight. The median 
plasma concentration of alpha-tocopherol (μmol/
l) among participants was 28.0 (25th: 75th per-
centile 20.5:36.6). Of the 49 participants for whom 
prior treatment information was available, 47% 
of the participants had received radiation therapy 
alone, another 45% had had surgery alone and the 
remainder (8%) had received both treatments. The 
time between date of diagnosis and collection of 
study samples ranged from 6 to 33 months (25th 
percentile: 8 months, 50th percentile: 10 months, 21
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75th percentile: 14 months). No patients were 
undergoing treatment at the time of biospecimen 
collection.
Six individual carotenoids were measured in 
plasma. Of these, lycopene and beta-carotene were 
the most abundant, whereas alpha-carotene and 
zeaxanthin were present in the lowest concentra-
tions (Table 2).
In unadjusted analyses, we examined median 
urinary F2-IsoP concentrations by a number of 
demographic (Table 3) and plasma nutrient variables 
(Table 4). We found statistically signiﬁ  cant inverse 
associations between plasma lutein and total 
F2-IsoPs in addition to total xanthophyll concentra-
tions and total F2-IsoPs (Table 4), as well as a 
statistically signiﬁ  cantly higher concentration of 
8-iso-PGF2α in current smokers compared to never 
and former smokers (Table 3). Smoking remained 
signiﬁ  cantly positively associated with 8-iso-PGF2α 
concentrations in the adjusted linear regression models 
for total carotenoids (beta = 0.7739, p = 0.047) and 
total carotenes (beta = 0.8188, p = 0.034). Although 
not signiﬁ  cant, the direction of association with 
8-iso-PGF2α remained positive in the adjusted model 
for total xanthophylls (beta = 0.6014, p = 0.104). 
Based on the 10% rule for confounding, we found 
that alpha-tocopherol was a confounder of each 
carotenoid~isoprostane association and thus was 
retained in the models. However, alpha-tocopherol 
was not a signiﬁ  cant predictor of either outcome at 
the 0.05 level.
In Table 5 we present unadjusted and adjusted 
associations between concentrations of the various 
carotenoid variables and total F2-IsoPs and 8-iso-
PGF2α from the linear regression models. Lutein 
and total xanthophylls were signiﬁ  cantly inversely 
associated with urinary concentrations of both total 
Table 1. Baseline characteristics of the study partici-
pants, N = 52.*
Characteristic Mean ± SD 
or number of 
subjects (%)
Age (years) 62.6 ± 11.7
Sex
 Male 38  (73.1)
 Female 14  (26.9)
Race
  White, non-Hispanic 50 (96.2)
 Other 2  (3.9)
Education
  Less than high school 5 (9.6)
  Some high school 25 (48.1)
   Technical/business school 
or college
15 (28.9)
   Graduate or professional 
school
7 (13.5)
Income (per yr)
   41 K 16 (30.8)
  41 K to  76 K 18 (34.6)
   76 K 10 (19.2)
 Unknown 8  (15.4)
Marital status
   Never/separated/widowed/
divorced
14 (26.9)
  Married/live as married 38 (73.1)
Alcohol consumption
  Never/occasional drinker 13 (25.0)
  Former regular drinker 17 (32.7)
  Current regular drinker 22 (42.3)
Smoking status
  Never/former smoker 45 (86.5)
  Current smoker 7 (13.5)
BMI (kg/m
2) 26.2 ± 4.9
Supplemental beta-carotene (IU)
 0 31  (59.6)
   0 and  5000 9 (17.3)
   5000 12 (23.1)
Dietary alcohol intake (g/d) 13.1 ± 31.2
Dietary vitamin C (mg/d) 82.0 ± 57.5
Fruit/vegetable intake 
(servings/d)
2.9 ± 1.9
*Column percentages may not sum to 100 due to rounding.
Table 2. Median plasma carotenoid concentrations of 
the study subjects (N = 52).
Carotenoid (μmol/l) Median (25th: 75th)*
Plasma alpha-carotene 0.048 (0.028:0.097)
Plasma beta-carotene 0.23 (0.10:0.45)
Plasma lutein 0.16 (0.11:0.22)
Plasma zeaxanthin 0.049 (0.033:0.066)
Plasma lycopene 0.30 (0.18:0.47)
Plasma beta-cryptoxanthin 0.071 (0.044:0.13)
Total plasma carotenoids 0.92 (0.63:1.51)
*Median values, as well as 25th and 75th quartiles are presented.22
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Table 3. Median and 25th: 75th percentile F2-isoprostane concentrations by demographic factors of interest.
Independent variable, divided 
at median if continuous
Total F2-IsoP, ng/ml urine 8-iso-PGF2α, ng/ml urine
Age (years)
   64.5 10.53 (6.94: 14.20) 1.03 (0.69: 1.36)
   64.5 12.97 (8.91: 16.79) 0.84 (0.44: 1.42)
Sex
  Male 10.74 (7.76: 15.53) 0.93 (0.65: 1.51)
  Female 12.46 (9.27: 16.81) 0.99 (0.60: 1.35)
Education
  Less than HS 12.92 (10.83: 14.33) 1.51 (0.84: 1.52)
  Some HS 13.64 (8.91: 16.79) 1.00 (0.68: 1.35)
  Technical/business school or college 9.27 (5.46: 16.04) 0.85 (0.29: 1.62)
  Graduate or professional school 9.31 (5.86: 12.32) 0.66 (0.37: 1.16)
Income (per yr)
   41K 12.59 (9.18: 17.58) 1.04 (0.58: 1.47)
 41K  to   76K 10.27 (6.57: 15.08) 0.89 (0.65: 1.62)
   76K 9.29 (6.94: 12.32) 0.88 (0.60: 1.10)
  Unknown 15.44 (11.71: 18.66) 1.10 (0.63: 1.57)
Marital status
  Never/separated/widowed/divorced 12.46 (6.91: 16.81) 0.99 (0.37: 1.52)
  Married/live as married 10.74 (8.11: 15.35) 0.93 (0.65: 1.36)
Alcohol consumption
  Never/occasional drinker 14.20 (10.64: 18.19) 1.25 (1.00: 1.36)
  Former/regular drinker 12.26 (7.02: 15.08) 0.93 (0.65: 1.27)
  Current/regular drinker 9.29 (6.57: 15.17) 0.81 (0.52: 1.62)
Smoking status
  Never/former 10.83 (7.76: 15.17) 0.87 (0.60: 1.27)
  Current smoker 16.81 (8.25: 18.38) 1.62 (0.94: 2.10)*
BMI (kg/m
2)
   25.85 10.24 (6.57: 15.08) 0.85 (0.60: 1.08)
   25.85 13.28 (9.26: 16.04) 1.21 (0.66: 1.52)
Supplemental beta-carotene (IU)
  0 10.83 (8.11: 16.79) 1.03 (0.78: 1.52)
   0 and  5000 15.17 (8.91: 16.04) 0.60 (0.29: 1.27)
   5000 11.46 (7.39: 15.31) 0.77 (0.60: 1.24)
Dietary vitamin C (mg/d)
   71.63 10.56 (6.94: 14.33) 1.02 (0.66: 1.36)
   71.63 12.11 (8.91: 16.04) 0.88 (0.60: 1.51)
Fruit/vegetable intake (servings/d)
   2.66 13.92 (9.09: 18.19) 1.04 (0.68: 1.42)
   2.66 9.44 (7.02: 13.73) 0.84 (0.54: 1.35)
*Denotes signiﬁ  cant difference (p   0.05) in median or mean transformed F2-isoprostane concentration across categories of the independent 
variable, assessed via Wilcoxon tests for binary independent variables and via single-factor ANOVA for independent variables with 
 2 categories.23
Carotenoids and biomarkers of oxidative stress
Biomarker Insights 2009:4
Table 4. Median and 25th: 75th percentile F2-isoprostane concentrations by plasma nutrient concentrations.
Independent variable, divided 
at median if continuous
Total F2-IsoP, ng/ml urine 8-iso-PGF2α, ng/ml urine
Alpha-carotene (μmol/l)
   0.048 12.62 (9.09: 18.19) 0.93 (0.62: 1.63)
   0.048 10.24 (6.57: 15.08) 0.98 (0.60: 1.27)
Beta-carotene (μmol/l)
   0.23 12.62 (8.25: 18.37) 1.00 (0.69: 1.63)
   0.23 10.24 (6.57: 14.33) 0.89 (0.44: 1.22)
Lutein (μmol/l)
   0.164 14.27 (10.47: 18.19) 1.11 (0.78: 1.52)
   0.164 9.29 (6.94: 13.02)* 0.84 (0.44: 1.22)
Zeaxanthin (μmol/l)
   0.0492 13.33 (8.91: 16.04) 0.97 (0.65: 1.35)
   0.0492 9.73 (6.91: 15.53) 0.86 (0.60: 1.42)
Lycopene (μmol/l)
   0.30 12.62 (8.91: 16.81) 0.93 (0.60: 1.51)
   0.30 10.27 (6.94: 15.35) 0.97 (0.62: 1.35)
Beta-cryptoxanthin (μmol/l)
   0.0705 12.59 (8.11: 18.38) 1.04 (0.78: 1.51)
   0.0705 10.71 (6.94: 15.35) 0.88 (0.54: 1.35)
Total xanthophylls
(μmol/l)
   0.3104 14.27 (9.09: 18.38) 1.04 (0.78: 1.52)
   0.3104 9.44 (6.57: 13.02)* 0.88 (0.54: 1.25)
Total carotenes (μmol/l)
   0.6337 12.62 (8.91: 18.37) 0.93 (0.66: 1.62)
   0.6337 10.24 (6.57: 15.08) 0.97 (0.52: 1.25)
Total carotenoids (μmol/l)
   0.918 12.62 (8.91: 18.37) 0.93 (0.66: 1.62)
   0.918 10.24 (6.57: 14.20) 0.97 (0.52: 1.25)
Alpha-tocopherol (μmol/l)
   28.00 12.59 (8.11: 18.19) 1.12 (0.84: 1.72)
   28.00 10.65 (7.76: 15.17) 0.77 (0.54: 1.22)
*Denotes signiﬁ  cant difference (p   0.05) in median or mean transformed F2-isoprostane concentration across categories of the independ-
ent variable, assessed via Wilcoxon tests for binary independent variables and via single-factor ANOVA for independent variables with  2 
categories.
F2-IsoPs and 8-iso-PGF2α in the unadjusted models. 
After control for potential confounders, these 
associations remained inverse, but were attenuated 
and no longer achieved statistical signiﬁ  cance. No 
statistically significant associations were seen 
between the individual or grouped carotenes and 
the F2-IsoP measures in the unadjusted or adjusted 
analyses.
Discussion
The primary goal of this study was to explore the 
relationships between the six major carotenoids 24
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quantiﬁ  able in human plasma (alpha-carotene, 
beta-carotene, lycopene, lutein, zeaxanthin and 
beta-cryptoxanthin), as well as total xanthophylls, 
total carotenes and total carotenoids, and urinary 
isoprostane concentrations of both total F2-IsoPs 
and 8-iso-PGF2α. Adjusted analyses failed to show 
statistically signiﬁ  cant associations between indi-
vidual or grouped carotenoids and the two F2-IsoP 
measures.
While not always achieving statistical signiﬁ  -
cance, the parameter estimates for xanthophylls in 
relation to biomarkers of lipid peroxidation were 
consistently negative, suggesting an inverse rela-
tion, which is consistent with previous ﬁ  ndings in 
the literature. Two in vitro studies speciﬁ  cally 
examining the xanthophylls demonstrated a protec-
tive effect of lutein and zeaxanthin against UVB-
induced lipid peroxidation.
48,49 Additionally, a 
study in 37 female adult subjects found a signiﬁ  -
cant inverse correlation between concurrent plasma 
xanthophyll (deﬁ  ned as the sum of plasma lutein 
and beta-cryptoxanthin concentrations) and urinary 
8-iso-PGF2α concentrations both before and after 
a two-week dietary intervention.
26
Inverse associations were not observed between 
total carotenes and either F2-IsoP measure in this 
study. In the literature, evidence for an association 
between the carotenes and urinary isoprostanes is 
mixed, with some studies showing a signiﬁ  cant 
protective effect
25,27,29 and others ﬁ  nding no sig-
niﬁ  cant association.
43
Our ﬁ  nding of a positive association between 
smoking and 8-iso-PGF2α is consistent with previ-
ous ﬁ  ndings in the literature. Two research groups 
found signiﬁ  cantly greater urinary excretion of 
F2-IsoP metabolites or 8-iso-PGF2α among smok-
ers than age- and sex-matched nonsmokers.
16,17 
Further analyses conducted by one of the groups 
revealed a signiﬁ  cant dose-response relationship 
between smoking exposure and urinary 8-iso-
PGF2α excretion, as well as a signiﬁ  cant decline in 
urinary 8-iso-PGF2α concentration after two or 
three weeks of smoking cessation.
17
One of the major strengths of this study was the 
use of the gold standard measurement technique for 
the F2-IsoPs, gas chromatography/mass spectros-
copy, GC/MS.
6 One group investigated whether the 
less time-consuming and expensive ELISA can be 
Table 5. Unadjusted and adjusted
† associations between concentrations of plasma carotenoids and urinary total 
F2-IsoP and 8-iso-PGF2α.
††
Carotenoid
Parameter 
estimate
for unadjusted 
association with 
total F2-IsoP, in 
ng per ml urine
(+/− standard 
error)*
§
Parameter 
estimate
for adjusted 
association with 
total F2-IsoP, in 
ng per ml urine
(+/− standard 
error)*
§
Parameter 
estimate
for unadjusted 
association with 
8-iso-PGF2α, in 
ng per ml urine
(+/− standard 
error)*
§
Parameter 
estimate
for adjusted 
association with 
8-iso-PGF2α, in 
ng per ml urine
(+/− standard 
error)*
§
Alpha-carotene −0.1611 ± 0.1789 0.0204 ± 0.2017 −0.0851 ± 0.1454 0.0979 ± 0.1621
Beta-carotene −0.0203 ± 0.1135 0.0753 ± 0.1308 −0.0630 ± 0.0914 0.0545 ± 0.1057
Lycopene −0.0657 ± 0.1929 −0.0305 ± 0.2320 0.1336 ± 0.1551 0.1797 ± 0.1851
Lutein −0.6569 ± 0.2240
§ −0.4564 ± 0.2753 −0.4968 ± 0.1832
§ −0.2075 ± 0.2275
Zeaxanthin −0.4543 ± 0.2355 −0.2783 ± 0.2858 −0.3466 ± 0.1913 −0.0939 ± 0.2331
Beta-cryptoxanthin −0.2761 ± 0.1661 −0.1574 + 0.2111 −0.1498 ± 0.1363 −0.0450 ± 0.1715
Total xanthophylls −0.6629 ± 0.2316
§ −0.4434 ± 0.2884 −0.4628 ± 0.1912* −0.1765 ± 0.2381
Total carotenes −0.0281 + 0.1589 0.0863 ± 0.1809 0.0161 ± 0.1285 0.1559 ± 0.1443
Total plasma 
carotenoids
−0.2315 ± 0.2032 −0.0398 ± 0.2417 −0.1079 ± 0.1658 0.1387 ± 0.1939
†Multivariate models for each carotenoid were adjusted for smoking, alcohol consumption, age, dietary vitamin C intake, plasma alpha-
tocopherol concentration, sex, BMI and education.
††Parameter estimates and associated p-values were obtained via simple and multiple linear regression, using transformed response and 
carotenoid variables.
*p   0.05.
§p   0.01.25
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used as a valid substitute for the GC/MS method, 
but weak agreement (Pearson correlation coefﬁ  cient 
0.51, 95% CI: 0.28–0.70 and weighted Kappa 
statistic 0.34) was found between these two 
methods.
50 The use of high-performance liquid 
chromatography (HPLC), as opposed to the thin-
layer chromatography method, to purify the F2-IsoPs 
prior to performing GC/MS in this study further 
enhanced the sensitivity and reproducibility of the 
assay.
46 An additional strength of the study was the 
measurement of urinary as opposed to plasma F2-
IsoPs, given that the former compounds are more 
stable and do not reﬂ  ect pathways of 8-iso-PGF2α 
formation other than free radical initiated peroxida-
tion of arachidonic acid.
6 Although urines were 
collected from a one-time sample during the day 
rather than totals over a 24-hour period, results from 
spot urines correlate well with those from 24-hour 
collections for the purpose of quantifying F2-IsoPs, 
in part because of the low variation in excretion of 
these compounds over the course of a day.
45,51,52
Other strengths of this study included the ability 
to examine the association between concentrations 
of the F2-IsoPs and carotenoids taken at the same 
point in time (the baseline visit of the Fruit and 
Vegetable Trial) and the ability to control for many 
potential confounders. In addition to the carotenoid 
variable of interest, each adjusted model included 
the following predictors: smoking status, alcohol 
consumption, age, dietary vitamin C, plasma alpha-
tocopherol, sex, BMI and education.
Limitations of this analysis include the small 
sample size (52 participants) and homogeneity of the 
study population, primarily white, formerly smoking 
males who had all been curatively treated for head 
and neck cancer, which could limit the generaliz-
ability of the results. The fact that such a low propor-
tion of the sample was classiﬁ  ed as current smokers 
was expected as these individuals had been diagnosed 
with and treated for head and neck cancer. However, 
the relative homogeneity of this sample in combina-
tion with a small sample size limited our power to 
detect significant inverse associations between 
several of the carotenoids and F2-IsoP outcomes. 
Also, as we performed multiple comparisons in these 
analyses, signiﬁ  cant ﬁ  ndings seen in the univariate 
comparisons could have arisen by chance.
Future research should continue to explore the 
precise nature of the relationship between the major 
carotenoids found in the plasma, in particular 
the xanthophylls given the promising findings 
reported in this study and others, and biomarkers 
of oxidative stress. As the F2-IsoPs are considered 
one of the most reliable markers of oxidative stress 
currently available,
6 studies should continue to 
incorporate these markers but in larger and more 
heterogeneous samples, and ideally in the setting 
of a cohort study in which the predictive ability of 
these and other markers can be assessed.
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